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Abstract
The direct alkynylation of benzofurans was achieved for the first time using the hypervalent iodine reagent 1-[(triiso-
propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (TIPS-EBX) based on the cooperative effect between a gold catalyst and a zinc
Lewis acid. High selectivity was observed for C2-alkynylation of benzofurans substituted with alkyl, aryl, halogen and ether
groups. The reaction was also successful in the case of the more complex drug 8-methoxypsoralen (8-MOP).
Introduction
Benzofurans are important heterocycles frequently encountered
in both bioactive compounds and organic materials (Figure 1).
For example, members of the furocoumarin class of natural
products including psoralen (1), 8-methoxypsoralen (2) and
angelicin (3) can cross-link with DNA upon light irradiation.
They have consequently been used for the treatment of skin
diseases such as cancer or psoriasis [1-4]. The natural product
coumestrol (4) is found especially in soy beans and has estro-
genic activity [5]. Synthetic bioactive compounds containing
benzofurans are also important, as exemplified by amiodarone
(5), as antiarrythmic drug [6,7]. Finally, benzofurans have also
emerged recently as important structural elements for organic
materials, such as the organic transistor 6 [8].
Due to the importance of benzofurans, the discovery of new
efficient methods for their synthesis and functionalization is an
intensive field of research [9-11]. Especially interesting would
be methods allowing the direct and regioselective C–H func-
tionalization of benzofurans [12]. In this context, the introduc-
tion of an alkyne would be particularly useful, as acetylenes are
important building blocks in synthetic chemistry, chemical
biology and materials science [13]. Nevertheless, to the best of
our knowledge, the direct alkynylation of benzofurans is still an
unknown process.
Since 2009, our group has developed a mild gold-catalyzed [14-
17] method for the alkynylation of electron-rich aryls such as
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Scheme 1: Zinc–gold catalyzed C2-alkynylation of benzofurans.
Figure 1: Benzofurans in bioactive compounds and materials.
indoles and pyrroles [18], thiophenes [19], anilines [20] and
furans [21]. Key for success was the use of ethynylbenziodox-
olones, which are cyclic hypervalent iodine reagents [22,23].
Nevertheless, the conditions we have used for other hetero-
cycles gave only very low yields in the case of benzofurans.
Herein, we would like to report the first catalytic direct
C2-alkynylation of benzofurans 7 based on a cooperative effect
between a gold catalyst and a zinc Lewis acid using 1-[(triiso-
propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (TIPS-EBX, 8)
as reagent (Scheme 1). The reaction proceeded under mild
conditions (60 °C under air) and could also be used to alkyny-
late the more complex polycyclic natural product 8-methoxy-
psoralen (2).
Findings
Benzofuran (7a) is less reactive then furans and indeed no prod-
uct was observed under the conditions optimized for the latter
[21] at room temperature or at 60 °C using the commercially
available electrophilic alkynylation reagent TIPS-EBX (8)
(Table 1, entries 1 and 2) [24-27]. Fortunately, benzofuran (7a)
was also more stable in the presence of acidic additives, and
co-activation became possible, whereas Zn(OTf)2 was superior
to trifluoroacetic acid (TFA) at 60 °C (Table 1, entries 3 and 4)
[19,28]. No product was observed in the absence of AuCl,
demonstrating the cooperative effect of the two metals (Table 1,
entry 5). Lower or higher temperatures did not increase the
yield (Table 1, entries 6 and 7). Finally, using a larger excess of
TIPS-EBX (8) and Zn(OTf)2 gave 75% yield of alkynylation
product 9a (Table 1, entry 8). The use of Zn(OTf)2 in catalytic
amount led to a lower yield (Table 1, entry 9), and a larger
excess resulted in decomposition of the starting material only
(Table 1, entry 10). Although other Lewis acids could also be
used (Table 1, entries 11 and 12) [29], no better results than
with Zn(OTf)2 were obtained (Table 1, entry 7). Importantly, in
contrast to our previous work with benzothiophenes [19], high
selectivity for C2 alkynylation was observed.
Table 1: Optimization of the alkynylation of benzofuran (7a).
Entrya Equiv 8 Additiveb T [°C] Yield
1 1.2 – 23 <5%
2 1.2 – 60 <5%
3 1.2 TFA 60 42%
4 1.2 Zn(OTf)2 60 56%
5 1.2 Zn(OTf)2c 60 <5%
6 1.2 Zn(OTf)2 40 48%
7 1.2 Zn(OTf)2 82 36%
8 2 Zn(OTf)2 60 75%
9 2 Zn(OTf)2d 60 37%
10 2 Zn(OTf)2e 60 0%
11 2 Zn(NTf)2 60 57%
12 2 Yb(OTf)3 60 62%
aReaction conditions: 7a (0.20 mmol) and AuCl (0.01 mmol) in acetoni-
trile (0.8 mL) under air for 26 h, isolated yield; bsame amount as 8;
cwithout gold catalyst; d0.2 equiv; e4.0 equiv.
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Scheme 2: Scope of the reaction.
Scheme 3: Alkynylation of 7-methoxybenzofuran (7j) [31].
The scope of the reaction was then investigated (Scheme 2).
Substitution by diverse functional groups was first examined on
the C5 position. An electron-rich methoxy group was well toler-
ated, giving the desired alkynylation product 9b in 73% yield.
The reaction was also successful with a bromide substituent
(product 9c), making the method orthogonal to classical cross-
coupling chemistry [30]. In presence of an aryl or an alkyl
substituent, alkynylation was also obtained in 72% and 50%
respectively (products 9d and 9e). Benzofurans substituted at
the C7 position could also be used, as demonstrated by the effi-
cient formation of alkynes 9f and 9g. In contrast, when
7-methoxybenzofuran (7j) was used, no C2 alkynylation prod-
uct could be isolated. Instead, a mixture of C4 and C6 alkyny-
lated benzofurans 9j and 9j’ was obtained (Scheme 3) [31].
Substitution on the furan ring was also possible at the C3 pos-
ition (product 9h), but the use of 2-methylbenzofuran (7i) led to
very a low yield in the alkynylation reaction.
Finally, we wondered if the alkynylation method could also be
successful in the case of more complex benzofuran-containing
natural products and drugs. We were pleased to see that the
alkynylation of 8-methoxypsoralen (2) was indeed possible. The
major product 10 bearing the acetylene group at the C5’ pos-
ition was obtained in 37% yield (Scheme 4) [32]. Although the
yield was still moderate, this was one of the first examples of
direct alkynylation of a marketed drug. It also gave access in a
single step to an interesting furocoumarin derivative with an
extended chromophore, which could be important for
phototherapy.
Mechanistically, the reaction could proceed either via π-acti-
vation of the triple bond by the gold catalyst followed by conju-
gate addition of the benzofuran, α-elimination and 1,2-shift, or
oxidative addition of TIPS-EBX (8) onto the gold catalyst
(either at the Au(I) or Au(0) oxidation level) followed by elec-
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Scheme 4: Alkynylation of 8-methoxypsoralen (2).
trophilic auration and reductive elimination [33]. The role of the
zinc Lewis acid is not completely clear at this stage, but it may
act by complexing the carboxylate group of the hypervalent
iodine reagent, enhancing its electrophilic reactivity [19,34]. In
fact, a complete shift of the 1H NMR signals of TIPS-EBX (8)
was observed when Zn(OTf)2 was added, whereas no signal
shift was observed when mixing the Lewis acid and benzofuran
(7a) [35].
In conclusion, the first direct alkynylation method of benzofu-
rans has been developed. Key for success was a cooperative
effect between a gold catalyst and a zinc Lewis acid, together
with the use of the hypervalent iodine reagent TIPS-EBX (8).
Preliminary results obtained with 8-methoxypsoralen (2)
demonstrated that the reaction could also be applied to more
complex furocoumarin natural products.
Experimental
General procedure for the alkynylation of benzofurans:
TIPS-EBX (8, 342 mg, 0.800 mmol, 2.0 equiv), AuCl (4.6 mg,
0.020 mmol, 0.050 equiv), Zn(OTf)2 (289 mg, 0.800 mmol,
2.0 equiv) and benzofuran 7 (0.40 mmol, 1.0 equiv) were added
into CH3CN (2.0 mL) under air. The mixture was stirred for
26 hours at 60 °C. Then the mixture was concentrated in pres-
ence of silica gel and purified directly by column chromatog-
raphy.
Supporting Information
Supporting Information File 1
Experimental part.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-9-204-S1.pdf]
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1. General Methods 
  All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, 
unless stated otherwise. For quantitative flash chromatography technical grade solvents were 
used. For flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were 
used. THF, Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated 
alumina under nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). NEt3 and 
pyridine were distilled under nitrogen from KOH. Gold chloride was purchased from Aldrich 
and kept in desiccator under anhydrous condition (decrease of reactivity has been observed 
for catalyst if prolonged exposition to air (ca 1 month). The solvents were degassed by 
Freeze-Pump-Thaw method when mentioned. All chemicals were purchased from Acros, 
Aldrich, Fluka, VWR, Aplichem or Merck and used as such unless stated otherwise. 
Chromatographic purification was performed as flash chromatography using Macherey-Nagel 
silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure.TLC was 
performed on Merck silica gel 60 F254 TLC glass plates or aluminium plates and visualized 
with UV light, permanganate stain, CAN stain or Anisaldehyde stain. Melting points were 
measured on a Büchi B-540 melting point apparatus using open glass capillaries, the data is 
uncorrected. 1H-NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer 
in chloroform-d, DMSO-d6 or CD3OD, all signals are reported in ppm with the internal 
chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm or the internal methanol 
signal at 3.30 ppm as standard. The data is being reported as (s =  singlet, d =  doublet, t =  
triplet, q =  quadruplet, qi =  quintet, m =  multiplet or unresolved, br =  broad signal, app =  
apparent, coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra were 
recorded with 1H-decoupling on a Brucker DPX-400 100 MHz spectrometer in chloroform-d, 
DMSO-d6 or CD3OD, all signals are reported in ppm with the internal chloroform signal at 
77.0 ppm, the internal DMSO signal at 39.5 ppm or the internal methanol signal at 49.0 ppm 
as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer 
with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 (w = weak, m =  
medium, s =  strong, br =  broad). Gas chromatographic and low resolution mass 
spectrometric measurements were performed on a Perkin-Elmer Clarus 600 gas 
chromatographer and mass spectrometer using a Perkin-Elemer Elite fused silica column 
(length: 30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution mass 
spectrometric measurements were performed by the mass spectrometry service of ISIC at the 
EPFL on a MICROMASS (ESI) Q-TOF Ultima API. HPLC measurement were done on a 
JASCO HPLC system with an AS2055 Autosampler, a PU 2089 Pump, a UV 2075 detector 
and a SEDEX 85 (SEDERE) detector using a CHIRALPAK IC column from DAICEL 
Chemical Industries Ltd. HPLC grade solvents from Sigma-Aldrich were used. 
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2.  Preparation of Reagents 
 
TIPS-EBX is commercially available, or can be synthesized using a reported procedure.1 
 
3. Synthesis of Starting Materials. 
 
5-Phenylbenzofuran (7d) 
 
A schlenk tube was charged with boronic acid 15 (152 mg, 1.25 mmol, 1.25 equiv), Pd(PPh3)4 
(57.5 mg, 0.0500 mmol, 0.05 equiv) , Na2CO3 (265 mg, 2.50 mmol, 2.50 equiv), DME (1.5 
mL) and H2O (3.5 mL). After degassing the mixture, 5-bromobenzofuran (7c) (196 mg, 1.00 
mmol, 1.0 equiv) was added. The mixture was heated to 90 oC and stirred overnight under N2. 
Then, the mixture was filtered through a plug of celite, and diluted with CH2Cl2 (10 mL). The 
organic layer was washed with 1 M NaOH (10 mL), brine (10 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (SiO2; Pentane) to afford 7d as a white solid (174 mg, 0.900 mmol, 90%). 
Rf (Pentane): 0.6. 
1H NMR (400 MHz, CDCl3) δ 7.82 (d, 1 H, J = 1.4 Hz; FuranH), 7.68 (d, 1 H, J = 2.2 Hz; 
ArH), 7.65 (dd, 2 H, J = 8.5, 1.3 Hz, ArH), 7.60 (d, 1 H, J = 8.5 Hz; ArH), 7.56 (dd, 1 H, J = 
8.6, 1.3 Hz, ArH), 7.48 (t, 2 H, J = 7.4 Hz, ArH), 7.38 (t, 1H, J = 7.4 Hz; ArH) 6.84 (d, 1 H, J 
= 1.4 Hz; FuranH) 13C NMR (101 MHz, CDCl3) δ 154.5, 145.6, 141.6, 136.4, 128.7, 127.9, 
127.4, 126.8, 123.9, 119.7, 111.5, 106.8. The NMR data corresponds to the literature.2 
5-Hexylbenzofuran (7e) 
 
                                                          
1 J. P. Brand, J. Waser, Synthesis 2012, 44, 1155. 
2 Varela-Fernandez, A.; Gonzalez-Rodriguez, C.; Varela, J.; Castedo, L.; Saa, C. Org. Lett. 2009, 11, 5350. 
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A schlenk tube was charged with boronic ester 16 (170 mg, 0.800 mmol, 1.0 equiv), 
Pd(PPh3)4 (46.2 mg, 0.0500 mmol, 0.05 equiv), Na2CO3 (85 mg, 2.5 mmol, 1.0 equiv), DME 
(1.0 mL) and H2O (2.5 mL). After degassing the mixture, 5-bromobenzofuran (7c) (173 mg, 
0.880 mmol, 1.1 equiv) was added. The mixture was heated to 90 oC and stirred overnight 
under N2. Then, the mixture was filtered through a plug of celite, and diluted with CH2Cl2 (10 
mL). The organic layer was washed with 1 M NaOH (10 mL), brine (10 mL), dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by column 
chromatography (SiO2; Pentane) to afford 7e as a colorless oil (77 mg, 0.38 mmol, 48%). 
Rf (Pentane): 0.5. 
1H NMR (400 MHz, CDCl3) δ 7.59 (d, 1 H, J = 2.2 Hz, FuranH), 7.41 (m, 2 H, ArH), 7.12 
(dd, 1 H, J = 8.4, 1.7 Hz, ArH), 6.72 (dd, 1 H, J = 2.2, 0.8 Hz, FuranH), 2.70 (m, 2 H, 
HexylH), 1.65 (m, 2 H, HexylH), 1.40-1.26 (m, 6 H, HexylH), 0.90 (t, 3 H, J = 7.0 Hz, 
HexylH). 13C NMR (101 MHz, CDCl3) δ 153.4, 144.9, 137.4, 127.4, 124.9, 120.3, 110.8, 
106.4, 35.9, 32.1, 31.7, 29.0, 22.6, 14.1. IR 2956 (m), 2928 (s), 2857 (m), 2362 (w), 1697 (w), 
1468 (s), 1331 (w), 1263 (m), 1197 (w), 1130 (m), 1113 (w), 1034 (w), 910 (w), 885 (w), 810 
(m), 764 (m), 737 (s). Anal. calcd. for C14H18O: C, 83.12%; 
 
 H, 8.97%. Found: C, 83.24%; H, 8.89%. 
 
7-Phenylbenzofuran (7g) 
 
 
A schlenk tube was charged with boronic acid (15) (89 mg, 0.73 mmol, 1.0 equiv), Pd(PPh3)4 
(42 mg, 0.050 mmol, 0.05 equiv) , Na2CO3 (77 mg, 0.73 mmol, 1.0 equiv), DME (1.0 mL) 
and H2O (2.5 mL). After degassing the mixture, 7-bromobenzofuran (7f) (158 mg, 0.880 
mmol, 1.1 equiv) was added. The mixture was heated to 90 oC and stirred overnight under N2. 
Then, the mixture was filtered through a plug of celite, and diluted with CH2Cl2 (10 mL). The 
organic layer was washed with 1 M NaOH (10 mL), brine (10 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (SiO2; Pentane) to afford 7g as a colorless oil (126 mg, 0.649 mmol, 89%). 
Rf (Pentane): 0.3. 
6 
 
1H NMR (400 MHz, CDCl3) δ 7.92 (m, 2 H, ArH), 7.72 (d, 1 H, J = 2.2 Hz, FuranH), 7.63 
(dd, 1 H, J = 7.7, 1.1 Hz, ArH), 7.55 (m, 2 H, ArH), 7.51 (dd, 1 H, J = 7.5, 1.1 Hz, ArH), 7.44 
(m, 1 H, ArH), 7.37 (m, 1 H, ArH), 6.87 (d, 1 H, J = 2.2 Hz, FuranH). 13C NMR (101 MHz, 
CDCl3) δ 152.2, 145.0, 136.5, 128.6, 128.5, 128.1, 127.6, 125.6, 123.8, 123.3, 120.4, 106.7. 
The NMR data corresponds to the literature.3 
 
                                                          
3 Otterlo, W.; Morgans, G.; Lee, M.; Kuzvidza, S.; Moleele, S.; Thornton, N.; Koning, C. T, Teth, Tetrahedron, 
2005 , 61, 7746.  
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4. Alkynylation Reactions 
 
Optimization of the reaction: 
General procedure: 
 
  
TIPS-EBX (8), AuCl (2.3 mg, 0.010 mmol, 0.050 equiv), additives were added into a solution 
of benzofuran (23.6 mg 0.200 mmol, 1.0 equiv) in CH3CN under air. Then the mixture was 
concentrated with silica gel and purified by column chromatography directly. 
 
 
 
 
 
General procedure (GP): TIPS-EBX (8) (342 mg, 0.800 mmol, 2.0 equiv), AuCl (4.6 mg, 
0.020 mmol, 0.050 equiv), Zn(OTf)2 (289 mg, 0.800 mmol, 2.0 equiv) and benzofuran 
derivatives 7 (0.40 mmol, 1.0 equiv) were added into CH3CN (2.0 mL) under air. The mixture 
was stirred for 26 hours at 60 oC. Then the mixture was concentrated with silica gel and 
purified by column chromatography directly. 
 
 
Equiv of TIPS-EBX Additive Temp (oC) Yield (%) 
1.2 - RT 0 
1.2 - 60 0 
1.2 1.2eq Zn(OTf)2 RT 22 
1.2 1.2eq  Zn(OTf)2 60 56 
1.2 1.2eq  Zn(OTf)2 40 48 
1.2 1.2eq  Zn(OTf)2 reflux 34 
2 2.0eq  Zn(OTf)2 60 75 
2 2.0eq  Zn(OTf)2 60 (0.1M) 34 
2 2.0eq  Zn(OTf)2 60 (0.8M) 68 
2 2.0eq TFA 60 34 
2 2.0eq Zn(BF4)2 60 0 
2 0.2eq  Zn(OTf)2 60 37 
2 4.0 eq. Zn(OTf)2 60 0 
2 2.0eq  Zn(NTf2)2 60 57 
2 2.0eq  Yb(OTf)3 60 62 
2 2.0eq  Zn(CF3COO)2 60 17 
2 2.0eq  ZnBr2 60 trace 
2 2.0eq  Zn(CH3COO)2 60 9 
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(Benzofuran-2-ylethynyl)triisopropylsilane (9a) 
 
 
 
 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane) to afford 9a as a yellow oil (90 mg, 0.30 mmol, 75%).  
 
Rf (Pentane): 0.6. 
1H NMR (400 MHz, CDCl3) δ 7.54 (d, 1 H, J = 7.8 Hz, ArH), 7.45 (m, 1 H, ArH), 7.33 (m, 1 
H, ArH), 7.21 (m, 1 H, ArH), 6.95 (s, 1 H, FuranH), 1.15 (m, 21 H, TIPS); 13C NMR (101 
MHz, CDCl3) δ 154.6, 138.7, 127.5, 125.6, 123.2, 121.2, 111.9, 111.2, 98.7, 96.2, 18.6, 11.2; 
IR 2943 (s), 2865 (s), 2155 (w), 2154 (w), 1558 (w), 1490 (w), 1463 (m), 1449 (m), 1261 (w), 
1181 (m), 1019 (w), 997 (m), 952 (w), 922 (w), 884 (s), 818 (w), 809 (w). HRMS (ESI) calcd 
for C19H26OSi[M]
+ 298.1753; found 298.1749. 
 
Triisopropyl((5-methoxybenzofuran-2-yl)ethynyl)silane (9b) 
 
 
 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane/DCM 100/1) to afford 9b as a yellow oil (96 mg, 0.29 mmol, 
73%).  
 
Rf (Pentane/DCM 100/1): 0.2. 
1H NMR (400 MHz, CDCl3) δ 7.33 (d, 1 H, J = 8.8 Hz, ArH), 6.97 (d, 1 H, J = 2.5 Hz, ArH), 
6.93 (dd, 1 H, J = 8.9, 2.6 Hz, ArH), 6.89 (s, 1 H, FuranH), 3.84 (s, 3 H, CH3), 1.14 (m, 21 H, 
TIPS); 13C NMR (151 MHz, CDCl3) δ 156.2, 149.6, 139.4, 128.0, 114.7, 112.0, 111.7, 103.0, 
98.5, 96.3, 55.8, 18.6, 11.2; IR 2946 (s), 2945 (s), 2866 (m), 2363 (w), 2156 (w), 1617 (w), 
1470 (s), 1299 (w), 1254 (w), 1210 (s), 1184 (m), 1032 (w), 997 (w), 956 (w), 883 (w). 
HRMS (ESI) calcd for C20H29O2Si
+ [M+H]+ 329.1931; found 329.1917. 
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((5-Bromobenzofuran-2-yl)ethynyl)triisopropylsilane (9c) 
 
 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane) to afford 9c as a yellow oil (96 mg, 0.26 mmol, 64%).  
 
Rf (Pentane): 0.7. 
1H NMR (400 MHz, CDCl3) δ 7.67 (d, 1 H, J = 1.9 Hz, ArH), 7.41 (dd, 1 H, J = 8.7, 1.9 Hz, 
ArH), 7.31 (d, 1 H, J = 8.7 Hz, ArH), 6.88 (s, 1 H, FuranH), 1.15 (m, 21 H, TIPS); 13C NMR 
(151 MHz, CDCl3) δ 153.3, 139.9, 129.5, 128.5, 123.7, 116.3, 112.7, 111.1, 99.7, 95.6, 18.6, 
11.2; IR 2945 (s), 2866 (s), 2362 (m), 2337 (w), 2159 (w), 1458 (s), 1321 (w), 1258 (w), 1206 
(w), 1180 (s), 1070 (w), 1057 (w), 1015 (w), 997 (w), 952 (w), 881 (m). HRMS (ESI) calcd 
for C38Br2H51O2Si2
+ [M]+ 753.1789; found 753.1802. 
 
 
 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane/Et2O 100/1) to afford 9d as a colorless oil (106 mg, 0.290 
mmol, 72%). 
 
Rf (Pentane/Et2O 100/1): 0.7. 
1H NMR (400 MHz, CDCl3) δ 7.72 (dd, 1 H, J = 1.8, 0.6 Hz, ArH), 7.60 (m, 2 H, ArH), 7.56 
(dd, 1 H, J = 8.6, 1.9 Hz, ArH), 7.47 (m, 3 H, ArH), 7.34 (m, 1 H, ArH), 6.99 (d, 1 H, J = 0.9 
Hz, FuranH), 1.17 (m, 21 H, TIPS); 13C NMR (101 MHz, CDCl3) δ 154.2, 141.3, 139.3, 
136.9, 128.8, 128.1, 127.4, 127.0, 125.4, 119.5, 112.1, 111.3, 98.9, 96.1, 18.6, 11.2; IR 2945 
(s), 2866 (s), 2363 (w), 2158 (w), 1462 (s), 1257 (w), 1240 (w), 1179 (m), 1073 (w), 1015 (w), 
998 (w), 954 (w), 884 (m), 814 (w). HRMS (ESI) calcd for C25H30OSi [M+] 374.2066; found . 
374.2057. 
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((5-Hexylbenzofuran-2-yl)ethynyl)triisopropylsilane (9e) 
 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane) to afford 9e as a colorless oil (77 mg, 0.20 mmol, 50%). 
 
Rf (Pentane): 0.6. 
1H NMR (400 MHz, CDCl3) δ 7.34 (d, 1 H, J = 8.4, ArH), 7.32 (d, 1 H, J = 0.9 Hz, ArH), 
7.14 (dd, 1 H, J = 8.4, 1.7 Hz, ArH), 6.89 (d, 1 H, J = 0.9 Hz, FuranH), 2.67 (t, 2 H, J = 7.5 
Hz, HexylH), 1.63 (m, 2 H, HexylH), 1.36-1.26 (m, 6 H, HexylH), 1.14 (m, 21 H, TIPS), 0.88 
(t, 3 H, J = 6.8 Hz, HexylH); 13C NMR (101 MHz, CDCl3) δ 153.2, 138.7, 137.9, 127.5, 126.4, 
120.2, 111.8, 110.7, 98.3, 96.4, 35.8, 32.0, 31.7, 28.9, 22.6, 18.6, 14.1, 11.2. IR 2946 (m),), 
2868 (m), 2361 (s), 2157 (w), 2114 (w), 1758 (w), 1727 (w), 1467 (w), 1264 (w), 1233 (w), 
1195 (w), 995 (w), 884 (w), 812 (w), 729 (m). HRMS (ESI) calcd for C25H39OSi
+ [M+H]+ 
383.2765; found 383.2782. 
 
((7-Bromobenzofuran-2-yl)ethynyl)triisopropylsilane (9f) 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane) to afford 9f as a colorless oil (119 mg, 0.316 mmol, 79%). 
 
Rf (Pentane): 0.4. 
1H NMR (400 MHz, CDCl3) δ 7.49 (dd, J = 4.9, 1.0 Hz, ArH), 7.47 (dd, 1 H, J = 4.9, 1.0 Hz, 
ArH), 7.11 (t, 1 H, J = 7.8 Hz, ArH), 7.00 (s, 1 H, FuranH), 1.19 (m, 21 H, TIPS). 13C NMR 
(101 MHz, CDCl3) δ 151.7, 139.5, 128.8, 128.5, 124.5, 120.2, 112.6, 103.9, 99.9, 95.5, 18.6, 
11.2. IR 2945 (m), 2866 (m), 2361 (w), 2158 (w), 1579 (w), 1465 (w), 1417 (w), 1304 (w), 
1223 (w), 1176 (m), 1137 (w), 1018 (w), 927 (m), 912 (w), 884 (w), 815 (w), 769 (w), 737 (s). 
HRMS (ESI) calcd for C38Br2H51O2Si2
+ [2M+H]+ 753.1789; found 753.1825. 
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Triisopropyl((7-phenylbenzofuran-2-yl)ethynyl)silane (9g) 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane) to afford 9g as a colorless oil (98 mg, 0.26 mmol, 65%). 
 
Rf (Pentane): 0.3. 
1H NMR (400 MHz, CDCl3) δ 7.87 (m, 2 H, ArH), 7.50 (m, 4 H, ArH), 7.40 (m, 1 H, ArH), 
7.32 (t, 1 H, J = 7.6 Hz, ArH), 7.02 (s, 1 H, FuranH), 1.16 (m, 21 H, TIPS).  13C NMR (101 
MHz, CDCl3) δ 151.8, 138.9, 136.2, 128.7, 128.6, 128.4, 127.7, 125.4, 125.1, 123.8, 120.2, 
112.3, 98.8, 96.3, 18.6, 11.2. IR 2945 (s), 2892 (w), 2866 (s), 2361 (s), 2156 (w), 1730 (w), 
1685 (w), 1564 (w), 1465 (m), 1409 (w), 1249 (w), 1210 (m), 1171 (w), 1017 (w), 998 (w), 
956 (w), 912 (w), 884 (m), 820 (w), 757 (s). HRMS (ESI) calcd for C25H31OSi
+ [M+H]+ 
375.2139; found 375.2142. 
 
Triisopropyl((3-methylbenzofuran-2-yl)ethynyl)silane (9h) 
 
 
 
Following a slightly modified version of GP, TIPS-EBX (8) (514 mg, 1.20 mmol, 3.0 equiv) 
and Zn(OTf)2 (434 mg, 1.20 mmol, 3.0 equiv) were used. The crude product was purified by 
flash column chromatography (SiO2; Pentane) to afford 9h as a colorless oil (72 mg, 0.23 
mmol, 58%).  
 
Rf (Pentane): 0.5. 
1H NMR (400 MHz, CDCl3) δ 7.52 (d, 1 H, J = 7.7 Hz ArH), 7.45 (d, 1 H, J = 8.0 Hz ArH), 
7.36 (t, 1 H, J = 8.0 Hz ArH), 7.29 (d, 1 H, J = 9.0 Hz ArH), 2.37 (s, 3 H, CH3), 1.19 (m, 21 H, 
TIPS); 13C NMR (101 MHz, CDCl3) δ 154.1, 136.0, 128.7, 125.6, 122.7, 121.9, 119.6, 111.2, 
100.8, 95.8, 18.6, 11.2, 8.9; IR 2943 (m), 2865 (m), 2154 (w), 1745 (w), 1463 (m), 1449 (s), 
1387 (w), 1353 (w), 1281 (w), 1250 (w), 1191 (s), 1116 (w), 1096 (m), 1071 (w), 1017 (w), 
997 (w), 920 (w), 883 (s). HRMS (ESI) calcd for C20H29OSi
+ [M+H]+ 313.1982; found 
313.1981. 
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Triisopropyl((7-methoxybenzofuran-4-yl)ethynyl)silane (9j) + Triisopropyl((7-
methoxybenzofuran-6-yl)ethynyl)silane (9j') 
 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane/DCM 100/1) to afford an inseparable mixture of two isomers 
9j and 9j' as yellow oil (66 mg, 0.20 mmol, 50%). 
 
Rf (Pentane/DCM 100/1): 0.5. 
1H NMR (400 MHz, CDCl3) δ 7.60 (d, 0.2 H, J = 2.1 Hz, ArH minor isomer), 7.58 (d, 1 H, J 
= 2.1 Hz, ArH major isomer), 7.32 (d, 0.2 H, J = 8.3 Hz, FuranH, minor isomer), 7.25 (d, 1 H, 
J = 8.3 Hz, FuranH, major isomer), 6.90 (d, 0.2 H, J = 2.1 Hz, ArH minor isomer), 6.82 (d, 1 
H, J = 2.1 Hz, ArH major isomer), 6.67 (d, 0.2H, J = 8.3 Hz, FuranH, minor isomer), 6.66 (d, 
1H, J = 8.3 Hz, FuranH, major isomer)  4.03 (s, 0.6 H, OCH3, minor isomer), 4.02 (s, 3 H, 
OCH3, major isomer), 1.16 (s, 21 H, TIPS, major isomer), 1.13 (s, 4 H, TIPS, minor isomer). 
13C NMR (151 MHz, CDCl3) δ 146.8, 145.9, 145.8, 145.4, 143.4, 131.9, 131.4, 129.6, 127.9, 
108.5, 106.9, 106.7, 106.5, 106.2, 104.5, 91.9, 89.7, 88.0, 76.1, 73.6, 56.2, 56.1, 29.7, 18.7, 
18.6, 11.3. IR 2943 (s), 2865 (s), 2362 (m), 2147 (m), 1619 (m), 1584 (w), 1497 (s), 1464 (m), 
1407 (w), 1336 (w), 1289 (s), 1258 (w), 1199 (w), 1176 (w), 1093 (m), 1044 (m), 915 (w), 
882 (m). HRMS (ESI) calcd for C20H29O2Si
+ [M+H]+ 329.1931; found 329.1928. 
 
2-((Triisopropylsilyl)ethynyl)-7H-furo[3,2-g]chromen-7-one (10) 
 
 
 
Following the conditions described in GP, the crude product was purified by flash column 
chromatography (SiO2; Pentane/EA 10/1) to afford 10 as yellow oil (58 mg, 0.15 mmol, 37%). 
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Rf  (Pentane/EA 10/1): 0.7. 
1H NMR (400 MHz, CDCl3) δ 8.22 (d, 1 H, J = 9.7 Hz, VinylH), 7.71 (s, 1 H, FuranH), 6.94 
(s, 1 H, ArH), 6.45 (d, 1 H, J = 9.7 Hz, VinylH), 4.33 (s, 3 H, CH3), 1.18 (m, 21 H, TIPS). 
13C 
NMR (101 MHz, CDCl3) δ 160.1, 146.9, 146.4, 142.9, 142.3, 133.4, 129.3, 117.8, 115.4, 
106.9, 106.7, 100.4, 100.1, 61.4, 18.7, 11.2. IR 2944 (w), 2866 (w), 2146 (w), 1742 (s), 1587 
(m), 1473 (m), 1423 (w), 1380 (w), 1310 (w), 1134 (s), 1046 (s), 1028 (w), 916 (w), 830 (w), 
814 (w). HRMS (ESI) calcd for C23H28NaO4Si
+ [M+Na]+ 419.1649; found 419.1657. 
 
2-Ethynyl-7H-furo[3,2-g]chromen-7-one (17) 
 
 
 
 290 μL TBAF (1M in THF, 0.29 mmol, 2.0 equiv) was added into a solution of 10 (53.0 mg, 
0.145 mmol, 1.0 equiv) in 2 mL dry THF. The solution was kept overnight then was quenched 
with sat NH4Cl (10 mL). The aqueous phase was extracted with DCM (3 × 5 mL). The 
combined organic phase was dried over MgSO4 and concentrated. The crude product was 
purified by  flash column chromatography (SiO2; Pentane/EA 5/1) to afford 17 as yellow solid. 
The yellow solid was washed by pentane to get pure compround (8 mg, 0.04 mmol, 26%).  
Rf:  (Pentane/EA 10/1): 0.4 
Melting point: 248-249 oC. 
1H NMR (400 MHz, CDCl3) δ 7.75 (d, 1 H, J = 9.6 Hz, VinylH), 7.32 (s, 1 H, ArH), 7.03 (s, 1 
H, FuranH), 6.39 (d, 1 H, J = 9.6 Hz, VinylH), 4.30 (s, 3 H, CH3), 3.56 (s, 1 H, CH). 
13C 
NMR (101 MHz, CDCl3) δ 160.1, 147.4, 144.1, 144.0, 139.6, 132.5, 125.7, 117.0, 115.2, 
113.0, 112.3, 84.7, 73.2, 61.4.  IR 3203 (w), 2363 (w), 1713 (s), 1620 (w), 1468 (w), 1400 (w), 
1324 (w), 1267 (w), 1237 (w), 1219 (w), 1164 (w), 1021 (w), 962 (w), 936 (w), 874 (w), 815 
(m), 776 (w), 760 (w). HRMS (ESI) calcd for C14H9O4
+ [M+H]+ 241.0495; found 241.0491. 
NMR Experiment 
TIPS-EBX (8) (43 mg, 0.10 mmol) and Zn(OTf)2 (36 mg, 0.10 mmol) were mixed in CDCl3 
(1 mL). 
1H NMR (400 MHz, CDCl3) δ 8.58 (m, 1 H, ArH), 8.20 (m, 1 H, ArH), 7.76 (m, 2 H, ArH), 
1.18 (m, 21 H, TIPS). 
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Figure S1: 1H NMR spectrum of Zn(OTF)2/TIPS-EBX (8) adduct 
5. Spectra of New Compounds 
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